Supplementary Table S1 from Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer
crossref(2023)
摘要
Supplementary Table S1. FDA approved HER2-targeted therapies
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要